Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Dinoprostone and Vitamin K

supplement:

Vitamin K

Research Papers that Mention the Interaction

Inhibition of PGE2 production by menatetrenone might be important in improving bone metabolism.
This study shows that menatetrenone inhibited PGE2 release from cells by inhibiting both PG production steps, AA release from the membrane and PG synthesizing activity with AA.
Biochemical pharmacology  •  1993  |  View Paper
Vitamin K2 had a synergistic effect with PGE2 on cancellous BV/TV as a result of the suppression of an increase in ES/BS observed by PGE2 treatment.
Calcified Tissue International  •  2006  |  View Paper
Menatetrenone at greater than 3 x 10(-6) M significantly inhibited the calcium …) M of 1,25(OH)2D3 or 10(-7) M of prostaglandin E2 , and it also inhibited osteoclast-like multinucleated cell (MNC) formation induced by …-culture of spleen cells and stromal cells at the same concentrations.
Bone  •  1995  |  View Paper
Menatetrenone (3 × 10−6‐3 × 10−5 M) inhibited the bone resorption induced by IL‐1α (2 U/ml), PGE2 (10−7 M), PTH (3 × 10−7 M), and 1,25‐(OH)2D3 (3 × 10−10 M) in a dose‐dependent manner.
Menatetrenone also inhibited the PGE2 production stimulated by IL‐1α.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  •  1993  |  View Paper
Vitamin K1 (1-100 microM) inhibited the release of PGI2 and prostaglandin E2 (PGE2) by bovine aortic endothelial cells in culture, as measured by radioimmunoassay of 6-keto-prostaglandin F1 alpha (6-keto-PGE1 alpha) and PGE2.
Biochemical pharmacology  •  1986  |  View Paper
In addition, vitamin K , in particularly MK-4 can suppress cyclooxygenase-2 expression and prostaglandin E2 production during osteoclast development, potentially contributing to the inhibition of bone resorption [4].
European Journal of Clinical Nutrition  •  2021  |  View Paper